HB766Introduced in the House
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Introduced by Aimee Freeman, District 98
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Where it stands
Effective date: 08/01/2026.
June 8, 2026
How did lawmakers vote?
House votes
2 recorded votes · each counted separately
Senate votes
1 recorded vote · each counted separately
HouseStage: House Vote on HB 766 CONCUR IN SENATE AMENDMENTS (#1694) · May 29, 2026
97
Yes
0
No
8
Absent or Not Voting
105 representatives recorded in this House vote. Colors show vote categories only, not whether a vote was good or bad.
See how each representative voted
| Representative | District | Vote |
|---|---|---|
| Danny McCormick | 1 | Yes |
| Steven Jackson | 2 | Yes |
| Tammy Phelps | 3 | Yes |
| Joy Walters | 4 | Yes |
| Dennis Bamburg | 5 | Yes |
| Michael Melerine | 6 | Yes |
| Lawrence Bagley | 7 | Absent |
| Raymond Crews | 8 | Yes |
| Dodie Horton | 9 | Yes |
| Wayne McMahen | 10 | Yes |
Bill history
Prefiled.
Under the rules, provisionally referred to the Committee on Insurance.
First appeared in the Interim Calendar on 2/27/2026.
Read by title, under the rules, referred to the Committee on Insurance.
Reported with amendments (10-0).
Read by title, amended, ordered engrossed, recommitted to the Committee on Appropriations.
Reported with amendments (18-0).
Read by title, amended, ordered reengrossed, passed to 3rd reading.
Scheduled for floor debate on 05/07/2026.
Read by title, returned to the calendar.
Notice given.
Scheduled for floor debate on 05/11/2026.
Called from the calendar.
Read third time by title, amended, roll called on final passage, yeas 93, nays 0. Finally passed, title adopted, ordered to the Senate.
Received in the Senate. Read first time by title and placed on the Calendar for a second reading.
Read second time by title and referred to the Committee on Insurance.
Reported with amendments.
Committee amendments read and adopted. Read by title and referred to the Legislative Bureau.
Reported without Legislative Bureau amendments. Read by title and passed to third reading and final passage.
Rules suspended. Senate floor amendments read and adopted. Read by title, passed by a vote of 37 yeas and 0 nays, and ordered returned to the House. Motion to reconsider tabled.
Received from the Senate with amendments.
Scheduled for concurrence on 05/29/2026.
Read by title, roll called, yeas 97, nays 0, Senate amendments concurred in.
Enrolled and signed by the Speaker of the House.
Signed by the President of the Senate.
Sent to the Governor for executive approval.
Signed by the Governor. Becomes Act No. 833.
Effective date: 08/01/2026.
Verify the information
- Official page on the Louisiana Legislature website
- House Committee Amendment #3140 INS Draft (amendment)
- House Committee Amendment #3336 INS Proposed (amendment)
- House Committee Amendment #4856 APP Draft (amendment)
- House Committee Amendment #5017 APP Proposed (amendment)
- House Floor Amendment #3823 Freeman Proposed (amendment)
- Senate Committee Amendment #4151 INS Proposed (amendment)
- Senate Committee Amendment #4063 INS Draft (amendment)
- Senate Floor Amendment #4247 Talbot Adopted (amendment)
- Analysis (supplement)
- Fiscal Note (supplement)
- Analysis (supplement)
- Fiscal Note (supplement)
- Fiscal Note (supplement)
- Analysis (supplement)
- Fiscal Note (supplement)
- Analysis (supplement)
- Fiscal Note (supplement)
- Analysis (supplement)
- Fiscal Note (supplement)
- Fiscal Note (supplement)
- Analysis (supplement)
- Fiscal Note (supplement)
- Introduced (text)
- Engrossed (text)
- Engrossed (text)
- Engrossed (text)
- Enrolled (text)
- Chaptered (text)
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.